Recent Articles
4 Hot Penny Stocks That Could See Outsized Gains
These four speculative stocks could rise well above current penny stock levels Editor’s note: This story was previously published in September 2018. It has since been republished and updated with new information. The potential to become wealthy often means investing in an enterprise when it is small and waiting for the entity to grow large. […]
7 Oversold Small-Cap Stocks With Massive Profit Growth
The recent bear move has opened up some interesting opportunities in small-cap stocks While the markets have made up lots of ground since the steep drop in the fourth quarter of 2018, there are still concerns. The upcoming earnings season could mean negative surprises for investors. Of course, we’ve already seen this with Apple (NASDAQ:AAPL). […]
Attis Industries (ATIS) Stock: An Investment Worth Your Consideration
Today’s market is one that is ripe with disruption. As innovation leads the charge and technology drives further advancements in how we do just about everything, a new breed of investment opportunity is being born. That’s where we get to Attis Industries (NASDAQ: ATIS). Attis Industries is a company that is driven by innovation to solve challenges in […]
Med-X: Why Investors Should Be Paying Attention
The world is changing, and so too are opinions. Today, opinions with regard to cannabis, pharmaceuticals, chemicals, and more are constantly being scrutinized. Med-X is a company that is riding on the leading edge of this change and creating a compelling opportunity in the process. What Is Med-X Med-X is a company that is becoming a disruptive force across multiple […]
AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing
Axsome Therapeutics (NASDAQ:AXSM) stock was flying high on Monday following some good AXSM news. The new bit of AXSM news from the company that has Axsome Therapeutics stock on the rise today has to do with recent results from a study. This comes from a Phase 2 trial of using its AXS-05 to treat major depressive disorder. The Phase […]
How To Determine Your #1 Financial Goal For The Year
Setting goals for the new year can be exciting. A majority of the goals people set relate to either finances or fitness. When it comes to improving your finances, there are so many goals you can set. It can almost seem overwhelming. I’ll be the first to admit that goal overload is not worth it. […]
10 Small-Cap Stocks That Look Like Bargains
The market’s bearish tide upended some small names that didn’t deserve it As bad as you think it’s been lately owners the market’s most familiar names, like Apple (NASDAQ:AAPL) and Amazon.com (NASDAQ:AMZN), it’s been even worse for fans of small-cap stocks. The Russell 2000 Index, which reflects the average performance of small cap equities, is now down a little more […]
7 Signs Will Confirm The End Is Near For The Market
The bull market run since March 2009, when unprecedented money printing became the economic driver du jour, recently become the longest in history without a 20%-plus correction. Past stock bubbles have lasted five years; six years max. This one is now 9.8 years old –off the charts. We have the unprecedented major tax cut and […]
Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib
We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring improved treatment options to patients, especially for some of the toughest-to-treat cancers. That’s where Trovagene (Nasdaq: TROV) comes in with their drug candidate, Onvansertib. Trovagene caught my attention […]
4 Reasons Why Marijuana Stocks Will Be More Stable In 2019
The year of the big pot pop isn’t over, but that doesn’t mean it’s time to throw in the towel on marijuana stocks If there was one investment that took the financial markets by storm in 2018, it was marijuana stocks. The group, headlined by Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), Aurora (NYSE:ACB), and Cronos (NASDAQ:CRON), […]
Share Price Rises As Groupon (GRPN) Takes To The Big Screen
Only last month, Groupon suffered its worst single day slide on the NASDAQ since May 21, 2007, when shares slid by 10.6% on Wednesday, November 7. The third quarter results for the company were also less than positive with profits of $593 million compared to the analysts projections of $602 million. At the time, there […]
